Geyer M, Howell-Jones R, Cunningham R, McNulty C
Department of Otolaryngology, Royal South Hants Hospital, Brintons Terrace, Southampton.
Br J Biomed Sci. 2011;68(4):174-80. doi: 10.1080/09674845.2011.11730346.
Otitis externa is a ubiquitous inflammatory disease; although it arises most commonly from an infection, there is no consensus in the UK for the reporting of ear swab culture results. This study aims to review current microbiology laboratory reporting of ear swab specimens to primary care and reach an evidence-based consensus for a reporting policy. Fifty consecutive ear swab reports were reviewed from each of 12 laboratories in the South West region to determine and discuss reporting practice. The Health Protection Agency (HPA) GP Microbiology Laboratory Use Group reviewed the underlying evidence and worked towards a consensus of expert microbiology opinion for laboratory reporting of ear swab results using a modified version of the Delphi technique. A total of 487 reports from primary care were reviewed (54% female; 46% male). Cultures most commonly yielded Pseudomonas species (36%), Staphylococcus species (21%), Streptococcus species (15%) and fungi (11%). Five reporting policies were agreed: Policy 1: Common pathogens such as group A beta-haemolytic streptococci, Streptococcus pneumoniae, Staphylococcus aureus - Always reported by name with antibiotic susceptibilities. Policy 2: Pseudomonas species - Always reported, but antibiotic susceptibilities only reported in severe disease. Policy 3: Aspergillus, Candida, coliforms and Proteus species, as well as non-group A streptococci and anaerobes - Only reported if moderate numbers of colonies and it is the predominant organism present; if appropriate report antibiotic susceptibilities. Policy 4: Coagulase-negative staphylococci, diphtheroids and enterococci - Not reported by name; generic terms used and antibiotic susceptibilities not reported. Policy 5: When antibiotic susceptibilities reported these must include susceptibility to a topical antibiotic. It is suggested that laboratories should consider adopting this evidence-based reporting consensus for ear swab culture results from primary care patients with otitis externa.
外耳道炎是一种常见的炎症性疾病;尽管它最常由感染引起,但在英国对于耳部拭子培养结果的报告尚无共识。本研究旨在回顾目前向基层医疗单位报告耳部拭子标本的微生物学情况,并达成基于证据的报告政策共识。从西南地区的12个实验室中各选取50份连续的耳部拭子报告进行回顾,以确定并讨论报告实践。健康保护局(HPA)的全科医生微生物学实验室使用小组审查了相关基础证据,并采用改良版德尔菲技术,努力达成微生物学专家对于耳部拭子结果实验室报告的共识。共审查了来自基层医疗单位的487份报告(女性占54%;男性占46%)。培养物中最常见的是假单胞菌属(36%)、葡萄球菌属(21%)、链球菌属(15%)和真菌(11%)。商定了五项报告政策:政策1:A组β溶血性链球菌、肺炎链球菌、金黄色葡萄球菌等常见病原体——始终按名称报告并附上抗生素敏感性。政策2:假单胞菌属——始终报告,但仅在严重疾病时报告抗生素敏感性。政策3:曲霉菌、念珠菌、大肠菌群和变形杆菌属,以及非A组链球菌和厌氧菌——仅在菌落数量适中且为主要存在的生物体时报告;如合适则报告抗生素敏感性。政策4:凝固酶阴性葡萄球菌、类白喉杆菌和肠球菌——不按名称报告;使用通用术语且不报告抗生素敏感性。政策5:报告抗生素敏感性时必须包括对局部用抗生素的敏感性。建议实验室应考虑采用这一基于证据的报告共识,用于基层医疗单位患有外耳道炎患者的耳部拭子培养结果报告。